🔎 Trials Near Me

Akèy › Ateroskleroz › Tennessee › Chattanooga

Etid klinik pou Ateroskleroz nan Chattanooga, TN

3 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Chattanooga (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Ap rekriteFaz 3
  • WR-Clinsearch, LLC, Chattanooga
  • Erlanger Health System, Chattanooga
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3
  • Southeast Renal Research Institute, Chattanooga
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Chattanooga
  • Research Site, Chattanooga
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Etid Ateroskleroz nan lòt vil

Lòt etid nan Chattanooga

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.